Stoychev & Stoycheva commented on the importan Di Maura EU VAT case in TV Europe on 23 July 2018. You can see how the conversation went by reviewing the interview herein below.
Abstract The pharmaceutical industry bears significant costs for research and development as well as the unpredictability of whether a new medicinal product shall reach the pharmaceutical market. Once a medicinal product is launched onto the market, the profits from this medicinal product should compensate the costs incurred for the medicinal products which did not reach
Stoychev & Stoycheva is the modern law firm where best practices and new trends meet. I am really happy by their services in the area of tax and employment law and recommend them to everyone.
